Cancer Today Logo
  • Subscriber Services
  • e-newsletter
  • Advertise
  • Contact Us
Skip to content
  • Cancer Types
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Kidney Cancer
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Thyroid Cancer
    • Uterine Cancer
    • cancer types a-z
  • Research Updates
    • All
    • Treatment
    • Prevention
    • Screening
    • Disparities
  • Living with Cancer
    • All
    • Survivor Profiles
    • Celebrity Stories
  • Support for You
    • All
    • Nutrition & Exercise
    • Well-being
    • Your Questions, Our Answers
    • Money Matters
    • Caregiving
  • Taking Action
    • All
    • Advocacy
    • Policy
    • Volunteering
    • Scientist↔Survivor Program
  • In the Magazine
    • Current Issue
    • Archives
  • Cancer Talk
    • Blog
    • Week in Cancer News
sponsored advertising content
  • Understanding Changes to Medicare Prescription Drug Coverage

    Understanding Changes to Medicare Prescription Drug Coverage

    The Inflation Reduction Act significantly changes what patients pay out-of-pocket for Medicare Part D prescription drugs in 2024.

    sponsored by Triage Cancer

  • When an Insurance Company Says No

    When an Insurance Company Says No

    Appealing health insurance coverage denials can improve access to timely care and lessen the financial burden of a cancer diagnosis.

    sponsored by Triage Cancer

  • A Father and Daughter Outlearn Lymphoma

    A Father and Daughter Outlearn Lymphoma

    The Lymphoma Research Foundation’s North American Educational Forum provides support to a father and daughter who both received blood cancer diagnoses.

    sponsored by the Lymphoma Research Foundation

  • Biomarker Testing in Lung Cancer

    Biomarker Testing in Lung Cancer

    Biomarker test leads to a targeted treatment option for woman with lung cancer.

    sponsored by Blueprint Medicines

Previous |
Fall 2026 subscribe today. digital edition past issues
get our free e-newsletter
subscribe
From the AACR
  • AACR OMB Statement and Call to Action
    AACR OMB Statement and Call to Action

    The AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.

  • AACR Cancer Disparities Progress Report
    AACR Cancer Disparities Progress Report

    The AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.

Video

Cancer Research at a Crossroads

More Videos

donate to the AACR

Foundation Ad
Cancer Today Logo
© 2026 AACR
The American Association for Cancer Research (AACR) is a 501(c)(3) registered nonprofit organization (23-6251648).
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
Phone: 215-440-9300
About Cancer Today
About the AACR
Advertise
Google Services Disclosure
Subscribe
Privacy Policy
Contact Us
Follow Us
Facebook Logo Twitter
Also of Interest:
  • A Response to Roadblocks
  • A Sense of Purpose
  • A Better Way to Screen for Lynch Syndrome?
This website uses cookies to ensure the best user experience.